A detailed history of Vista Investment Management transactions in Amgen Inc stock. As of the latest transaction made, Vista Investment Management holds 3,352 shares of AMGN stock, worth $1.04 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares
3,352
Previous 2,931 14.36%
Holding current value
$1.04 Million
Previous $844,000 12.91%
% of portfolio
0.4%
Previous 0.4%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$268.87 - $324.56 $113,194 - $136,639
421 Added 14.36%
3,352 $953,000
Q4 2023

Feb 14, 2024

SELL
$255.7 - $288.46 $2,812 - $3,173
-11 Reduced 0.37%
2,931 $844,000
Q3 2023

Nov 13, 2023

SELL
$218.65 - $271.46 $17,929 - $22,259
-82 Reduced 2.71%
2,942 $790,000
Q2 2023

Aug 14, 2023

SELL
$214.27 - $253.37 $1,928 - $2,280
-9 Reduced 0.3%
3,024 $671,000
Q1 2023

May 15, 2023

BUY
$225.79 - $275.2 $14,450 - $17,612
64 Added 2.16%
3,033 $733,000
Q4 2022

Feb 13, 2023

SELL
$229.03 - $291.01 $2,977 - $3,783
-13 Reduced 0.44%
2,969 $779,000
Q3 2022

Nov 14, 2022

SELL
$224.46 - $253.15 $3,366 - $3,797
-15 Reduced 0.5%
2,982 $672,000
Q2 2022

Aug 12, 2022

SELL
$230.71 - $256.74 $1,845 - $2,053
-8 Reduced 0.27%
2,997 $729,000
Q1 2022

May 13, 2022

SELL
$219.27 - $242.57 $1,096 - $1,212
-5 Reduced 0.17%
3,005 $727,000
Q4 2021

Feb 14, 2022

BUY
$198.88 - $227.6 $6,960 - $7,966
35 Added 1.18%
3,010 $677,000
Q3 2021

Nov 15, 2021

BUY
$212.27 - $248.7 $17,830 - $20,890
84 Added 2.91%
2,975 $633,000
Q2 2021

Aug 16, 2021

BUY
$233.58 - $259.14 $1,868 - $2,073
8 Added 0.28%
2,891 $705,000
Q1 2021

May 12, 2021

SELL
$221.91 - $258.6 $5,769 - $6,723
-26 Reduced 0.89%
2,883 $717,000
Q4 2020

Feb 12, 2021

SELL
$216.38 - $257.67 $64,048 - $76,270
-296 Reduced 9.24%
2,909 $669,000
Q3 2020

Nov 16, 2020

SELL
$234.65 - $260.95 $4,458 - $4,958
-19 Reduced 0.59%
3,205 $815,000
Q2 2020

Aug 13, 2020

SELL
$197.81 - $242.74 $12,857 - $15,778
-65 Reduced 1.98%
3,224 $760,000
Q1 2020

May 15, 2020

SELL
$182.24 - $241.7 $4,738 - $6,284
-26 Reduced 0.78%
3,289 $667,000
Q4 2019

Feb 14, 2020

SELL
$189.21 - $243.2 $2,270 - $2,918
-12 Reduced 0.36%
3,315 $799,000
Q3 2019

Nov 15, 2019

BUY
$174.11 - $208.62 $16,714 - $20,027
96 Added 2.97%
3,327 $644,000
Q2 2019

Aug 14, 2019

BUY
$166.7 - $195.41 $4,667 - $5,471
28 Added 0.87%
3,231 $595,000
Q1 2019

May 16, 2019

BUY
$180.87 - $203.88 $56,431 - $63,610
312 Added 10.79%
3,203 $609,000
Q3 2018

Nov 14, 2018

SELL
$185.29 - $208.89 $185 - $208
-1 Reduced 0.03%
2,891 $599,000
Q1 2018

May 15, 2018

SELL
$169.43 - $198.0 $86,917 - $101,574
-513 Reduced 15.07%
2,892 $493,000
Q4 2017

May 15, 2018

BUY
$168.79 - $188.59 $574,729 - $642,148
3,405
3,405 $592,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $166B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Vista Investment Management Portfolio

Follow Vista Investment Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vista Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Vista Investment Management with notifications on news.